RedC Biotech, Ltd.
RedC Biotech is a pre-clinical, development stage company focused on saving lives worldwide by developing a process to create universal red blood cells from stem cells. Their innovative technology aims to address the global shortage of blood transfusions by providing a safe, clean, and cost-effective alternative to traditional donor-based blood supplies.
Industries
biotechnology
health-care
medical
Products
Universal donor‑free red blood cell transfusion product
A red blood cell product manufactured from stem cells designed to be donor-free, pathogen-free, uniform in quality and intended to function with potency comparable to conventionally sourced red blood cells.
Universal donor‑free red blood cell transfusion product
A red blood cell product manufactured from stem cells designed to be donor-free, pathogen-free, uniform in quality and intended to function with potency comparable to conventionally sourced red blood cells.
Services
Collaborative R&D partnerships
Partnerships with industry, academic and government organizations to develop and scale a stem cell‑derived red blood cell product using a licensed cultivation platform.
Collaborative R&D partnerships
Partnerships with industry, academic and government organizations to develop and scale a stem cell‑derived red blood cell product using a licensed cultivation platform.
Expertise Areas
- Cellular product development from stem cells
- Bioprocess scale-up and manufacturing
- Downstream processing for cell therapies
- Process automation for biologics production
Key Technologies
- Stem cell cultivation and erythroid differentiation
- Large-volume cell culture bioreactors
- Automated bioprocessing workflows
- Downstream cell harvesting and concentration